VivoSeq
Musculoskeletal

Idiopathic Scoliosis

15

Pipeline Programs↗

3

Active Trials↗

10

Companies Involved↗

Idiopathic Scoliosis is an emerging landscape with 15 programs across 10 companies. The most active players are Boehringer Ingelheim, Amring, Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. 9 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

43/100

Pipeline Velocity

6/100

Mech. Concentration

27/100

Completion Rate

82/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Boehringer Ingelheim logo

Boehringer Ingelheim

1 program

Phase 2A

Amring

1 program

Phase 2P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Phase 2Luye Pharma Group Ltd. logo

Luye Pharma Group Ltd.

1 program

Phase 2M

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

1 program

ApprovedT

TLC Biopharmaceuticals, Inc.

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

15

clinical trials

Completed9 · 60%
Terminated2 · 13%
Not yet recruiting2 · 13%
Recruiting1 · 7%
Unknown status1 · 7%

Clinical Trials

Trial Activity

15 trials

Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion
Recruiting·TTanta University·N/A·NCT06820190·40 enrolled
Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Not yet recruiting·PPoznan University of Medical Sciences·Phase 4·NCT06789016·60 enrolled
Evaluating the Impact of a Smartphone App on Health Outcomes and Treatment Adherence in Adolescents With Idiopathic Scoliosis: A Mixed Method Quasi-Experimental Study
Not yet recruiting·Oslo Metropolitan University·Preclinical·NCT07686848·30 enrolled
Analgesic Efficacy of Mid-Transverse Process to Pleura (MTP) Block and Intrathecal Morphine in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion
Completed·TTanta University·N/A·NCT06331143·40 enrolled
Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery
Completed·FFundació Sant Joan de Déu·Phase 2·NCT02571491·48 enrolled
Palonosetron vs Ondansetron In PONV Prophylaxis Among Idiopathic Scoliosis Patients
Completed·UUniversity of Malaya·Phase 4·NCT05956899·92 enrolled
IV Methadone Vs EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Idiopathic Scoliosis Correction
Completed·—·Phase 4·NCT05730920·30 enrolled
Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Completed·PPoznan University of Medical Sciences·Phase 4·NCT06086431·90 enrolled
Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis
Completed·—·Phase 4·NCT02651324·50 enrolled
Ghrelin Resistance in Adolescents With Idiopathic Scoliosis
Completed·UUniversity Hospital, Toulouse·N/A·NCT02829476·45 enrolled
Dexamethasone for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Completed·PPoznan University of Medical Sciences·Phase 4·NCT06616220·60 enrolled
Does Tranexamic Acid Decrease Blood Loss in Pediatric Idiopathic Scoliosis Surgery?
Completed·—·Phase 1/2·NCT01813058·120 enrolled
Non-Idiopathic Scoliosis Treated With Tranexamic Acid
Terminated·TThe Hospital for Sick Children·Phase 2·NCT01089140·2 enrolled
A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair
Terminated·MMayo Clinic·Phase 4·NCT05552443·27 enrolled
Erector Spinae Plane Block for Pediatric Idiopathic Scoliosis Surgery
Unknown status·PPoznan University of Medical Sciences·Phase 4·NCT05938959·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)